Market Research Reports and Industry Reports

Valeant Canada LP - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical company that manufactures, markets and distributes pharmaceutical products. The company offers its products in various therapeutic areas, including pain management, neurology, cardiovascular disease, and dermatology. Its products include aczone, aldara, benzaclin, biacna, dermatix ultra, dermatop, dermatop II, efudex, elidel, glumetza, lodalis, loprox, nitoman, noritate and ovita, among others. Valeant Canada markets its products to pharmacies, healthcare practices and hospitals. The company operates manufacturing facilities in Manitoba, Ontario and Quebec. Valeant Canada is headquartered in Laval, Quebec, Canada.

Valeant Canada LP - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Valeant Canada LP, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Valeant Canada LP, Medical Devices Deals, 2011 to YTD 2017 9
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Valeant Canada LP, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Valeant Canada Acquires Canadian Rights from Sanofi-aventis for Altace and Altace HCT 11
Valeant Canada Acquires Dermatology Products from Valeo Pharma for USD23 Million 12
Partnerships 13
Orexigen Therapeutics Enters into Distribution Agreement with Valeant for Contrave 13
Licensing Agreements 14
Valeant Canada Enters into Licensing Agreement with Takeda Pharma for Edarbi and Edarbyclor 14
Acquisition 15
Valeant Canada Acquires CROMA Pharma Canada 15
Valeant Canada LP - Key Competitors 16
Valeant Canada LP - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Legal and Regulatory 18
Apr 05, 2016: Valeant Canada: COLD-FX Lawsuit Media Statement 18
Other Significant Developments 19
Jun 13, 2016: Valeant Canada announces an investment of $10 million in Laval facility to increase and secure its export capacity 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables

List of Tables
Valeant Canada LP, Pharmaceuticals & Healthcare, Key Facts 2
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Valeant Canada LP, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Valeant Canada LP, Deals By Therapy Area, 2011 to YTD 2017 8
Valeant Canada LP, Medical Devices Deals, 2011 to YTD 2017 9
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Valeant Canada Acquires Canadian Rights from Sanofi-aventis for Altace and Altace HCT 11
Valeant Canada Acquires Dermatology Products from Valeo Pharma for USD23 Million 12
Orexigen Therapeutics Enters into Distribution Agreement with Valeant for Contrave 13
Valeant Canada Enters into Licensing Agreement with Takeda Pharma for Edarbi and Edarbyclor 14
Valeant Canada Acquires CROMA Pharma Canada 15
Valeant Canada LP, Key Competitors 16
Valeant Canada LP, Other Locations 17

Valeant Canada LP - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical company that manufactures, markets and distributes pharmaceutical products. The company offers its products in various

USD 250View Report

Valeant Pharmaceuticals International Inc (VRX) - Medical Equipment - Deals and Alliances Profile.

Valeant Pharmaceuticals International Inc (Valeant) is a pharmaceutical and medical device company that carries out development, manufacture and marketing of several branded, over-the-counter (OTC) and generic drugs. The company also

USD 250View Report

Valeant Canada Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Valeant Canada Ltd (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical company that develops, manufactures and markets pharmaceutical products. The companys products include aczone, aldara, benzaclin,

USD 250View Report

Valeant Canada Limited Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Valeant Canada Limited Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)


+91 9987 2952 42

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Dec 2017
No. of Pages :20
Country :Canada
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube